ORIBIOTECH LTD
ORIBIOTECH LTD
Contact & Details
Contact
Registered Address
First Floor, 3 Cumbrian House 217 Marsh Wall London E14 9FJ United Kingdom
Full company profile for ORIBIOTECH LTD (09757696), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 2 Sept 2015. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2020–2024)
Cash in Bank
£12.83M
Net Assets
£23.22M
Total Liabilities
£2.40M
Turnover
£474.00k
Employees
56
Debt Ratio
9%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (8)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 4 | Jan 2020 | Series B, Series A, Seed |
| Investor 5 | Jan 2020 | Series B, Series A, Seed |
| Investor 8 | Jan 2020 | Series A, Seed |
See all 8 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Paul Matthew Meister | Director | American | United States | 23 Dec 2021 | Active |
See all 14 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Farlan Singh Veraitch
Ceased 20 Aug 2019
Group Structure
Group Structure
No group structure identified
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 12 Mar 2026 | Capital | Allotment of shares (GBP 3,374.7035) on 2025-12-23 | |
| 30 Jan 2026 | Capital | Capital Variation Of Rights Attached To Shares | |
| 30 Jan 2026 | Capital | Capital Name Of Class Of Shares | |
| 16 Jan 2026 | Officers | Termination of Farlan Singh Veraitch as director on 2026-01-09 | |
| 16 Jan 2026 | Officers | Termination of Barry Clare as director on 2026-01-09 |
Allotment of shares (GBP 3,374.7035) on 2025-12-23
Capital Variation Of Rights Attached To Shares
Capital Name Of Class Of Shares
Termination of Farlan Singh Veraitch as director on 2026-01-09
Termination of Barry Clare as director on 2026-01-09
Recent Activity
Latest Activity
Allotment of shares (GBP 3,374.7035) on 2025-12-23
1 months ago on 12 Mar 2026
Capital Variation Of Rights Attached To Shares
2 months ago on 30 Jan 2026
Capital Name Of Class Of Shares
2 months ago on 30 Jan 2026
Termination of Farlan Singh Veraitch as director on 2026-01-09
3 months ago on 16 Jan 2026
Termination of Barry Clare as director on 2026-01-09
3 months ago on 16 Jan 2026